The groundbreaking research result of Pharmacoidea Kft., based in Szeged – a new diagnostic procedure for the early detection of Alzheimer’s disease from blood – has been shortlisted at the Reuters Events Pharma Awards in the category “Most Valuable Scientific Breakthrough/Discovery”. Pharmacoidea’s outstanding research has been supported in several projects by the National Research, Development and Innovation Fund and continues to receive support.

Research into modern, effective medicines for psychiatric and gynaecological diseases, advancing renewable fuel production, and developing an AI-based system that enhances national security by predicting geopolitical crises – these and similar products and services, significantly improving people’s wellbeing and sense of security, will be created from the nearly HUF 15 billion funding framework announced at the end of last year by the National Research, Development and Innovation Office (NRDI Office) for the large enterprise sector.

Health is something we truly appreciate when we don’t have it. When we are well, we don’t even think about it; we take it for granted. But fortunately, there are those who make con-siderable efforts to identify – and solve – health problems affecting society. A good example in Hungary is the HU-rizon Programme of the National Research, Development and Innovation Office (NRDI Office) that promotes international research collaborations between leading Hungarian research institutions, focusing not only on healthy living but also on the challenges of digitalisation and the green transition.

The XPAND Program, initiated by the National Innovation Agency (NIÜ), is designed to help Hungarian startups and SMEs enter international markets, connect with global investors, and expand their business networks.